Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cells
{{output}}
Background: Production of chimeric antigen receptor T cell (CAR-T) therapies depends on antibody reagents to label, isolate, and expand T cell products. We sought to create antibody tools specific for the variable domain of heavy... ...
